D. Braumann

809 total citations
28 papers, 568 citations indexed

About

D. Braumann is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Braumann has authored 28 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Braumann's work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Acute Myeloid Leukemia Research (3 papers). D. Braumann is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Acute Myeloid Leukemia Research (3 papers). D. Braumann collaborates with scholars based in Germany, Belgium and Estonia. D. Braumann's co-authors include Axel Stang, Carsten Bokemeyer, W. Teichmann, Roman Fischbach, Karl‐Friedrich Becker, Jacques De Grève, Muriel Debois, Philippe Vergauwe, Eric Van Cutsem and Ullrich Bethe and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

D. Braumann

28 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Braumann Germany 14 331 174 165 135 100 28 568
P Dufour France 8 385 1.2× 60 0.3× 112 0.7× 103 0.8× 76 0.8× 24 532
Woo Kun Kim South Korea 13 376 1.1× 78 0.4× 242 1.5× 107 0.8× 56 0.6× 36 643
Süheyla Serdengeçti Türkiye 14 165 0.5× 62 0.4× 97 0.6× 101 0.7× 30 0.3× 42 449
Evin Büyükünal Türkiye 13 197 0.6× 31 0.2× 152 0.9× 103 0.8× 34 0.3× 37 406
John Champion United States 14 171 0.5× 43 0.2× 221 1.3× 88 0.7× 48 0.5× 16 464
R Ignoffo United States 6 385 1.2× 361 2.1× 225 1.4× 224 1.7× 20 0.2× 7 633
Sheldon Kaufman United States 13 356 1.1× 65 0.4× 245 1.5× 247 1.8× 26 0.3× 31 666
Anna Ermacora Italy 13 288 0.9× 59 0.3× 55 0.3× 103 0.8× 205 2.0× 27 579
KC Lakshmaiah India 13 324 1.0× 31 0.2× 184 1.1× 70 0.5× 44 0.4× 74 563
Jurjen Versluis Netherlands 13 305 0.9× 91 0.5× 132 0.8× 48 0.4× 240 2.4× 43 747

Countries citing papers authored by D. Braumann

Since Specialization
Citations

This map shows the geographic impact of D. Braumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Braumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Braumann more than expected).

Fields of papers citing papers by D. Braumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Braumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Braumann. The network helps show where D. Braumann may publish in the future.

Co-authorship network of co-authors of D. Braumann

This figure shows the co-authorship network connecting the top 25 collaborators of D. Braumann. A scholar is included among the top collaborators of D. Braumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Braumann. D. Braumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stang, Axel, Roman Fischbach, W. Teichmann, Carsten Bokemeyer, & D. Braumann. (2009). A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. European Journal of Cancer. 45(10). 1748–1756. 103 indexed citations
2.
Stang, Axel, et al.. (2009). Differentiation of Benign From Malignant Focal Splenic Lesions Using Sulfur Hexafluoride–Filled Microbubble Contrast-Enhanced Pulse-Inversion Sonography. American Journal of Roentgenology. 193(3). 709–721. 48 indexed citations
3.
Braumann, D., et al.. (2008). Erscheinungsformen der extrapulmonalen Tuberkulose. DMW - Deutsche Medizinische Wochenschrift. 116(16). 611–616. 1 indexed citations
4.
Stang, Axel, et al.. (2007). Percutanous and Intraoperative Ultrasound-Guided Radiofrequency Ablation of Hepatic Tumours. Ultraschall in der Medizin - European Journal of Ultrasound. 28(2). 181–188. 5 indexed citations
6.
Stang, Axel, et al.. (2006). Kontrastmittel in der Abdomensonographie: aktueller Stand und Perspektiven. DMW - Deutsche Medizinische Wochenschrift. 131(33). 1813–1818. 1 indexed citations
7.
Grève, Jacques De, Julia Hartmann, Philippe Vergauwe, et al.. (2006). Capecitabine plus irinotecan versus 5-FU/FA/irinotecan ± celecoxib in first line treatment of metastatic colorectal cancer (CRC). Long-term results of the prospective multicenter EORTC phase III study 40015. Journal of Clinical Oncology. 24(18_suppl). 3577–3577. 25 indexed citations
10.
Stang, Axel, D. Braumann, & W. Teichmann. (2004). Mukozele der Appendix. DMW - Deutsche Medizinische Wochenschrift. 129(43). 2295–2298. 6 indexed citations
11.
Wein, A., T Lehnert, Torsten Liersch, et al.. (2004). Toxicity and safety of weekly high-dose 5-FU as 24-h infusion and folinic acid (AIO regimen) in adjuvant therapy of UICC stage III colon cancer. InTACT: A multicenter phase III trial. Journal of Clinical Oncology. 22(14_suppl). 3586–3586. 1 indexed citations
12.
Siveke, Jens T., et al.. (2003). Progrediente L�hmungen infolge eines strahleninduzierten zervikalen malignen peripheren Nervenscheidentumors. HNO. 51(10). 825–828. 2 indexed citations
13.
Buhr, T., Florian Länger, Jérôme Schlué, et al.. (2002). Reliability of lymphoma classification in bone marrow trephines. British Journal of Haematology. 118(2). 470–476. 15 indexed citations
14.
Hänel, Mathias, Nicolaus Kröger, M. Hoffknecht, et al.. (2000). ASHAP - an effective salvage therapy for recurrent and refractory malignant lymphomas. Annals of Hematology. 79(6). 304–311. 9 indexed citations
15.
Kröger, Nicolaus, Tatjana Zabelina, William Krüger, et al.. (2000). Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Bone Marrow Transplantation. 26(7). 711–716. 21 indexed citations
16.
Kröger, Nicolaus, William Krüger, S. Hegewisch-Becker, et al.. (1998). Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplantation. 22(11). 1029–1033. 21 indexed citations
17.
Haferlach, Torsten, W. Gaßmann, H. Löffler, et al.. (1993). Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. Annals of Hematology. 66(4). 165–170. 22 indexed citations
18.
Braumann, D., Peter Buggisch, Nils Eckardt, et al.. (1992). Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinoma. European Journal of Cancer. 28(11). 1820–1823. 18 indexed citations
19.
Braumann, D., et al.. (1990). Myokardinfarkte im Rahmen einer 5-Fluorouracil-Therapie. Oncology Research and Treatment. 13(6). 465–467. 2 indexed citations
20.
Mainzer, K., et al.. (1987). IgE myelomatosis. Annals of Hematology. 55(1). 55–60. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026